In vivo treatment with anti-α4 integrin suppresses clinical and pathological evidence of Borna disease virus infection

Journal of Neuroimmunology

Volumn 84, Issue 2, 1998, Pages 158-163

  Rubin, S A ^a,b   Yednock, T A ^c   Carbone, K M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Athena Neurosciences Inc   (United States)

Author keywords

4 Integrin; Disease; Inflammation; Virus

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORNA DISEASE; BORNA DISEASE VIRUS; DRUG EFFECT; DRUG SCREENING; IMMUNE RESPONSE; IMMUNOTHERAPY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, CD; BORNA DISEASE; ENCEPHALITIS, VIRAL; INTEGRIN ALPHA4; MALE; RATS; RATS, INBRED LEW; RECEPTORS, LYMPHOCYTE HOMING; RNA VIRUSES; VIRAL LOAD; WEIGHT GAIN;

EID: 0032522116     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00249-X     Document Type: Article

References (37)

1. Alon R., Kassner P.D., Carr M.W., Finger E.B., Hemler M.E., Springer T.A. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1995;1243-1253.
2. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Surface expression of alpha-4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
3. Bautista J.R., Rubin S.A., Moran T.H., Schwartz G.J., Carbone K.M. Developmental injury to the cerebellum following perinatal Borna disease virus infection. Dev. Br. Res. 90:1995;45-53.
4. Bode L., Zimmermann W., Freszt R., Steinbach F., Ludwig H. Borna disease virus genome transcribed and expressed in psychiatric patients. Nat. Med. 1:1995;232-236.
5. Cannella B., Cross A.H., Raine C.S. Adhesion-related molecules in the central nervous system: upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Lab. Invest. 65:1991;23-31.
6. Carbone K.M., Duchala C.S., Griffin J.W., Kincaid A.L., Narayan O. Pathogenesis of Borna disease in rats: evidence that intra-axonal spread is the major route of dissemination and the determinant for disease incubation. J. Virol. 61:1987;3431-3440.
7. Carlos T.M., Schwartz B.R., Kovach N.L., Yee E., Rosso M., Osborn L., Chi-Rosso G., Newman B., Lobb R.R., Harlan J.M. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 76:1990;965-970.
8. Christensen J.P., Andersson E.C., Scheynius A., Marker O., Thomsen A.R. Alpha-4 integrin directs virus-activated CD8+ T cells to sites of infection. J. Immunol. 154:1995;5293-5301.
9. Cross A.H., Cannella B., Brosnan C.F., Raine C.S. Homing to central nervous system vasculature by antigen-specific lymphocytes: I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63:1990;162-170.
10. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/firbronectin binding site. Cell. 60:1990;577-584.
11. Faull R.J., Ginsberg M.H. Dynamic regulation of integrins. Stem Cells. 13:1994;38-46.
12. Hemler M.E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:1990;365-400.
13. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:1991;254-260.
14. Issekutz T.B. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody: a likely role for VLA-4 in vivo. J. Immunol. 147:1991;4178-4184.
15. Issekutz T.B. Lymphocytes homing to sites of inflammation. Curr. Opin. Immunol. 4:1992;287-293.
16. 4 integrin throughout active experimental allergic encephalomyelitis. Neurology. 47:1996;1053-1059.
17. Kishi M., Nakaya T., Nakamura Y., Zhong Q., Ikeda K., Senjo M., Kakinuma M., Kato S., Ikuta K. Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cells. FEBS Lett. 15:1995;293-297.
18. Long M.W. Blood cell cytoadhesion molecules. Exp. Hematol. 20:1992;288-301.
19. Meerschaert J., Furie M.B. The cell adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1 and VCAM-1, and other ligands on endothelium. J. Immunol. 154:1995;4099-4112.
20. O'Neill J.K., Butter C., Baker D., Gschmeissner S.E., Kraal G., Butcher E.C., Turk J.L. Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology. 72:1991;520-525.
21. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 62:1990;3-6.
22. Planz O., Bilzer T., Stitz L. Immunopathogenic role of T-cell subsets in Borna disease virus-induced progressive encephalitis. J. Virol. 69:1995;896-903.
23. Raine C.S., Cannella B., Duijvestijn A.M., Cross A.H. Homing to central nervous system vasculature by antigen-specific lymphocytes: II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63:1990;476-489.
24. Richt J.A., Vande-Woude S., Clements J.E., Herzog S., Frese K., Stitz L., Narayan O. Molecular and immunopathological studies of Borna disease virus infection in rats. Behring Inst. Mitt. 89:1991;163-176.
25. Richt J.A., Schmeel A., Frese K., Carbone K.M., Narayan O., Rott R. Borna disease virus-specific T cells protect against or cause immunopathological Borna disease. J. Exp. Med. 179:1994;1467-1473.
26. Rott, R., Becht, H., 1995. Borna Disease. In: Koprowski, H., Lipkin, W.I. (Eds.), Springer-Verlag, Berlin, pp. 17-30.
27. Sato T., Tachibana K., Nojima Y., D'Avirro N., Morimoto C. Role of the VLA-4 molecule in T cell costimulation: identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4. J. Immunol. 155:1995;2938-2947.
28. Shimizu Y., Shaw S. Lymphocyte interactions with extracellular matrix. FASEB. 5:1991;2292-2299.
29. Shimizu Y., Seventer G.A., Horgan K.J., Shaw S. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J. Immunol. 145:1990;59-67.
30. Shimizu Y., Newman W., Tanaka Y., Shaw S. Lymphocyte interactions with endothelial cells. Immunol. Today. 13:1992;106-112.
31. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
32. Steffen B.J., Butcher E.C., Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system of the SJL/J mouse. Am. J. Pathol. 145:1994;189-201.
33. Stitz, L., Dietzchold, B., Carbone, K.M., 1995. Borna Disease. In: Koprowski, H., Lipkin, W.I. (Eds.), Springer-Verlag, Berlin, pp. 75-92.
34. Waltrip R.W. Jr., Buchanan R.W., Summerfelt A., Breier A., Carpenter W.T., Bryant N.L., Rubin S.A., Carbone K.M. Borna disease virus and schizophrenia. Psychiatry Res. 56:1995;33-44.
35. Wekerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. TINS. 9:1986;271-277.
36. Wekerle H., Sun D., Oropeza-Wekerle R.L., Meyermann R. Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. J. Exp. Biol. 132:1987;43-57.
37. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha-4 beta-1 integrin. Nature. 356:1992;63-66.